Ohio State’s Comprehensive Stroke Center not only offers the lifesaving care and rehabilitation you need following a stroke, but we’re also at the forefront of stroke research and breakthroughs.
As one of the largest academic medical centers in the country, The Ohio State University Wexner Medical Center leads the way in outstanding education, research and patient care. We provide the latest treatments and interventions, many of which may not be found at other hospitals.
We hold a pivotal role nationally in the study of strokes. The research arm of our stroke program examines every aspect of the condition, using innovative surgery techniques as well as finding ways to prevent strokes and treat them better using tools we already have.
Some of the stroke clinical trials the Ohio State Wexner Medical Center participates in are sponsored by companies or initiated by our own health care providers and scientists.
What is StrokeNet?
The National Institutes of Health (NIH) created StrokeNet to conduct large and small clinical trials to advance stroke treatment, prevention and rehabilitation.
StrokeNet is made up of 27 regional medical centers and involves about 500 hospitals nationwide, including Ohio State Wexner Medical Center. It’s designed to serve as the infrastructure and platform for exciting new treatments for people who have a stroke or are at risk of having a stroke.
The Ohio State Wexner Medical Center is also a member of two other important NIH initiatives — NeuroNEXT and the Neurological Emergencies Treatment Trials network — both of which strive to improve emergency care and treatment of strokes.
Ohio State stroke clinical trials
There are currently more than two dozen stroke-related clinical trials occurring at Ohio State. They focus on a range of topics from prevention methods to emergency interventions to best rehabilitation tactics.
Here’s a sampling of the amazing work and breakthroughs being uncovered at Ohio State:
- A clinical trial to look at the effectiveness of the clot-busting drug tPA when it’s used in combination with certain blood thinners
- A clinical trial to determine the effects of continuing or discontinuing statins in those with a risk of a second brain hemorrhage
- A study to examine whether the treatment of obstructive sleep apnea with positive airway pressure reduces recurrent strokes and improves outcomes following an ischemic stroke
- A clinical trial to determine the effectiveness of the drug apixaban versus aspirin in certain people who’ve had a stroke with unknown causes (cryptogenic stroke)
- A study to compare outcomes of stroke patients who were taken to the hospital by a special Mobile Stroke Treatment Unit with outcomes of those taken by an ambulance (in partnership with OhioHealth and Mount Carmel)
- A study being done by the Aphasia Lab at The Ohio State University on genetic and cognitive predictors in restorative language therapy response
Enrolling in a clinical trial
People in the community who participate in clinical trials and studies at Ohio State help researchers translate scientific discovery into lifesaving treatments and expand quality of life for many.
Participants in this research are vital to our mission of innovation and care.
To see a list of our most current stroke studies, visit our main research page and use stroke as a keyword when searching for opportunities.